|
OMIM |
Link |
Information gain |
01 |
|
centralopathic epilepsy
|
[NCBI]
|
0.00118764
|
|
|
intelligence quantitative trait locus 2
|
[NCBI]
|
0.00102539
|
|
|
intelligence quantitative trait locus 3
|
[NCBI]
|
0.00102539
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
0.00101328
|
|
|
SPG9
|
[NCBI]
|
0.000725612
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
0.000662821
|
|
|
microcephaly, autosomal dominant
|
[NCBI]
|
0.000486675
|
|
|
SRS
|
[NCBI]
|
0.000476138
|
|
|
ADHD
|
[NCBI]
|
0.000459523
|
|
|
MRX1
|
[NCBI]
|
0.000431005
|
|
|
GTS
|
[NCBI]
|
0.000426214
|
|
|
CHAT
|
[NCBI]
|
0.000377989
|
|
|
DYX1
|
[NCBI]
|
0.00025583
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000254316
|
|
|
TS
|
[NCBI]
|
0.000149412
|
|
|
sotos syndrome
|
[NCBI]
|
0.000147413
|
|
|
feingold syndrome
|
[NCBI]
|
0.000128683
|
|
|
NF1
|
[NCBI]
|
0.000114518
|
|
|
COH1
|
[NCBI]
|
9.34894e-05
|
|
|
ACHE
|
[NCBI]
|
9.32441e-05
|
|
|
arterial occlusive disease, progressive, with hypertension, heart defects, bone fragility, and brachysyndactyly
|
[NCBI]
|
8.94311e-05
|
|
|
epilepsy, myoclonic, x-linked, with mental retardation and spasticity
|
[NCBI]
|
8.94311e-05
|
|
|
suprabulbar paresis, congenital
|
[NCBI]
|
8.94311e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
8.93973e-05
|
|
|
yemenite deaf-blind hypopigmentation syndrome
|
[NCBI]
|
8.09651e-05
|
|
|
MRT2
|
[NCBI]
|
7.5473e-05
|
|
|
MRPL40
|
[NCBI]
|
7.36979e-05
|
|
|
SYNPO
|
[NCBI]
|
7.36979e-05
|
|
|
CPLX2
|
[NCBI]
|
7.36979e-05
|
|
|
subglottic bar
|
[NCBI]
|
7.13933e-05
|
|
|
FMR1
|
[NCBI]
|
7.01572e-05
|
|
|
chromosome 18p deletion syndrome
|
[NCBI]
|
6.81454e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
6.54472e-05
|
|
|
THRB
|
[NCBI]
|
6.51356e-05
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
6.11243e-05
|
|
|
ADRA2A
|
[NCBI]
|
5.99231e-05
|
|
|
GRM5
|
[NCBI]
|
5.99231e-05
|
|
|
CRBN
|
[NCBI]
|
5.99231e-05
|
|
|
GCLC
|
[NCBI]
|
5.99231e-05
|
|
|
SCZD4
|
[NCBI]
|
5.7728e-05
|
|
|
BDNF
|
[NCBI]
|
5.6635e-05
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
5.37003e-05
|
|
|
GRTH
|
[NCBI]
|
5.25576e-05
|
|
|
CTHM
|
[NCBI]
|
5.25576e-05
|
|
|
DYX2
|
[NCBI]
|
5.14924e-05
|
|
|
DLG4
|
[NCBI]
|
5.13558e-05
|
|
|
GRM1
|
[NCBI]
|
5.13558e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
5.04948e-05
|
|
|
HSR
|
[NCBI]
|
4.51958e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
4.51958e-05
|
|
|
NAGS
|
[NCBI]
|
4.51958e-05
|
|
|
CLN1
|
[NCBI]
|
4.35826e-05
|
|
|
histidinemia
|
[NCBI]
|
4.29751e-05
|
|
|
SIM2
|
[NCBI]
|
4.25369e-05
|
|
|
PAK3
|
[NCBI]
|
4.1436e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
4.02541e-05
|
|
|
PKS
|
[NCBI]
|
3.97637e-05
|
|
|
SYP
|
[NCBI]
|
3.95472e-05
|
|
|
CADASIL
|
[NCBI]
|
3.75249e-05
|
|
|
NSD1
|
[NCBI]
|
3.59867e-05
|
|
|
TBX1
|
[NCBI]
|
3.59867e-05
|
|
|
UBE3A
|
[NCBI]
|
3.54076e-05
|
|
|
PWS
|
[NCBI]
|
3.45962e-05
|
|
|
TH
|
[NCBI]
|
3.37678e-05
|
|
|
DYT1
|
[NCBI]
|
3.23136e-05
|
|
|
SOX10
|
[NCBI]
|
3.21039e-05
|
|
|
CTNS
|
[NCBI]
|
3.2024e-05
|
|
|
AS
|
[NCBI]
|
3.13633e-05
|
|
|
ARX
|
[NCBI]
|
3.06242e-05
|
|
|
LKS
|
[NCBI]
|
3.01443e-05
|
|
|
SLC6A3
|
[NCBI]
|
2.86087e-05
|
|
|
ND
|
[NCBI]
|
2.8483e-05
|
|
|
DBI
|
[NCBI]
|
2.65099e-05
|
|
|
COMT
|
[NCBI]
|
2.59699e-05
|
|
|
IDE
|
[NCBI]
|
2.34916e-05
|
|
|
KRAS
|
[NCBI]
|
2.33319e-05
|
|
|
SLE
|
[NCBI]
|
2.31577e-05
|
|
|
NS1
|
[NCBI]
|
2.3009e-05
|
|
|
ARSA
|
[NCBI]
|
2.24276e-05
|
|
|
SMS
|
[NCBI]
|
2.18605e-05
|
|
|
SNCA
|
[NCBI]
|
2.17368e-05
|
|
|
APOE
|
[NCBI]
|
2.09031e-05
|
|
|
MTTL1
|
[NCBI]
|
2.06119e-05
|
|
|
RASA1
|
[NCBI]
|
2.0266e-05
|
|
|
MS
|
[NCBI]
|
1.99491e-05
|
|
|
BBS
|
[NCBI]
|
1.91474e-05
|
|
|
CDK5
|
[NCBI]
|
1.81612e-05
|
|
|
TNF
|
[NCBI]
|
1.77253e-05
|
|
|
SST
|
[NCBI]
|
1.69173e-05
|
|
|
MAP2
|
[NCBI]
|
1.64661e-05
|
|
|
PTEN
|
[NCBI]
|
1.58313e-05
|
|
|
PSEN1
|
[NCBI]
|
1.52412e-05
|
|
|
DGS
|
[NCBI]
|
1.43001e-05
|
|
|
APP
|
[NCBI]
|
1.42858e-05
|
|
|
WBS
|
[NCBI]
|
1.31251e-05
|
|
|
PYY
|
[NCBI]
|
1.23883e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.12757e-05
|
|
|
CNTF
|
[NCBI]
|
8.01638e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
7.51672e-06
|
|
|
NGFB
|
[NCBI]
|
7.05356e-06
|
|
|
GDNF
|
[NCBI]
|
4.73816e-06
|
|
|
NPY
|
[NCBI]
|
4.47518e-06
|
|
|
ALD
|
[NCBI]
|
4.45962e-06
|
|
|
MDD
|
[NCBI]
|
2.27091e-06
|
|
|
FTD
|
[NCBI]
|
1.66677e-06
|
|
|
GFAP
|
[NCBI]
|
1.54468e-06
|
|
|
VIP
|
[NCBI]
|
1.27983e-06
|
|
|
CD
|
[NCBI]
|
1.07826e-06
|
|
|
AD
|
[NCBI]
|
6.21914e-07
|
|
|
EPO
|
[NCBI]
|
5.57746e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.83727e-07
|
|
|
HGF
|
[NCBI]
|
2.905e-08
|
|